# reload+after+2024-01-21 18:45:15.416593
address1§200 Talcott Ave
address2§2nd Floor
city§Watertown
state§MA
zip§02472
country§United States
phone§617 952 0555
website§https://werewolftx.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule that is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule, which is in Phase I clinical trial for the treatment of advanced or metastatic solid tumors and lymphoma. The company is also developing JZP898, a conditionally activated interferon alpha INDUKINE molecule for the treatment of cancer; and WTX-712, an IL-21 INDUKINE molecule for the treatment of cancer. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Watertown, Massachusetts.
fullTimeEmployees§46
companyOfficers§[{'maxAge': 1, 'name': 'Dr. Daniel J. Hicklin Ph.D.', 'age': 59, 'title': 'Founder, CEO, President, Secretary & Director', 'yearBorn': 1964, 'fiscalYear': 2022, 'totalPay': 817308, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Cynthia  Seidel-Dugan Ph.D.', 'age': 64, 'title': 'Chief Scientific Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 600354, 'exercisedValue': 0, 'unexercisedValue': 6865}, {'maxAge': 1, 'name': 'Dr. Randi  Isaacs M.D.', 'age': 67, 'title': 'Chief Medical Officer', 'yearBorn': 1956, 'fiscalYear': 2022, 'totalPay': 637149, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Timothy W. Trost CPA', 'age': 65, 'title': 'CFO, Treasurer & Assistant Secretary', 'yearBorn': 1958, 'fiscalYear': 2022, 'totalPay': 511878, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Chulani  Karunatilake Ph.D.', 'age': 64, 'title': 'Chief Technology Officer', 'yearBorn': 1959, 'fiscalYear': 2022, 'totalPay': 343431, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Ellen A. Lubman M.B.A.', 'age': 47, 'title': 'Chief Business Officer', 'yearBorn': 1976, 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§2
payoutRatio§0.0
beta§0.462
priceToSalesTrailing12Months§7.5409207
currency§USD
dateShortInterest§1702598400
forwardEps§-1.46
pegRatio§-0.56
exchange§NMS
quoteType§EQUITY
shortName§Werewolf Therapeutics, Inc.
longName§Werewolf Therapeutics, Inc.
firstTradeDateEpochUtc§1619789400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§07b61817-4b0c-36bb-893c-b622112d893f
gmtOffSetMilliseconds§-18000000
targetHighPrice§15.0
targetLowPrice§9.0
targetMeanPrice§12.8
targetMedianPrice§15.0
recommendationMean§1.2
recommendationKey§strong_buy
numberOfAnalystOpinions§5
quickRatio§9.417
grossMargins§-0.86534
ebitdaMargins§-1.516
trailingPegRatio§None
